Biotin–thiamine–responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment
暂无分享,去创建一个
[1] R. Wibom,et al. Biotin and Thiamine Responsive Basal Ganglia Disease--A vital differential diagnosis in infants with severe encephalopathy. , 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[2] I. Davagnanam,et al. Teaching NeuroImages: Biotin-responsive basal ganglia disease , 2016, Neurology.
[3] Mnahi Bin Saeedan,et al. Teaching NeuroImages: MRI findings of biotin-responsive basal ganglia disease before and after treatment , 2016, Neurology.
[4] I. Jonassen,et al. Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy , 2016, PloS one.
[5] M. Alfadhel,et al. Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine alone. , 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[6] N. Matsumoto,et al. Biotin-responsive basal ganglia disease: a case diagnosed by whole exome sequencing , 2015, Journal of Human Genetics.
[7] T. Farid,et al. Biotin-Responsive Basal Ganglia Disease: Neuroimaging Features before and after Treatment , 2014, American Journal of Neuroradiology.
[8] J. Abdenur,et al. Whole exome sequencing reveals compound heterozygous mutations in SLC19A3 causing biotin-thiamine responsive basal ganglia disease , 2014, Molecular genetics and metabolism reports.
[9] A. Warsy,et al. Is consanguinity prevalence decreasing in Saudis?: A study in two generations. , 2014, African health sciences.
[10] Garry K. Brown. Defects of thiamine transport and metabolism , 2014, Journal of Inherited Metabolic Disease.
[11] T. Acker,et al. Stress‐Induced Upregulation of SLC19A3 is Impaired in Biotin‐Thiamine‐Responsive Basal Ganglia Disease , 2014, Brain pathology.
[12] K. Amunts,et al. Biotin-responsive Basal Ganglia disease: a treatable differential diagnosis of leigh syndrome. , 2013, JIMD reports.
[13] S. Rahman,et al. Treatable Leigh-like encephalopathy presenting in adolescence , 2013, BMJ Case Reports.
[14] M. Alfadhel,et al. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases , 2013, Orphanet Journal of Rare Diseases.
[15] M. Blankenburg,et al. Biotin-responsive basal ganglia disease in a 10-year-old German girl without SLC19A3 gene mutation , 2013 .
[16] S. Khan,et al. Biotin-responsive basal ganglia disease revisited , 2013, Neurology.
[17] J. Obeso,et al. Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency , 2012, Movement disorders : official journal of the Movement Disorder Society.
[18] S. Tsuji,et al. A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations , 2010, BMC Medical Genetics.
[19] D. Galanaud,et al. Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations. , 2010, Archives of neurology.
[20] U. Muthane,et al. Biotin-Responsive Basal Ganglia Disease: A Treatable and Reversible Neurological Disorder of Childhood , 2009, Journal of child neurology.
[21] M. Mikati,et al. Biotin-responsive basal ganglia disease: case report and review of the literature. , 2008, Neuropediatrics.
[22] B. Adhisivam,et al. Biotin responsive limb weakness. , 2007, Indian pediatrics.
[23] T. Gillis,et al. Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. , 2005, American journal of human genetics.
[24] G. Gascon,et al. Biotin-responsive basal ganglia disease: a novel entity. , 1998, Brain : a journal of neurology.